Anavex Life Sciences Corp. (AVXL)
3.93
+0.05
(+1.29%)
USD |
NASDAQ |
Feb 12, 16:00
3.93
0.00 (0.00%)
After-Hours: 16:59
Anavex Life Sciences Market Cap : 364.20M for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 579.49M |
| Verastem, Inc. | 440.62M |
| Ocugen, Inc. | 459.88M |
| AnaptysBio, Inc. | 1.521B |
| Replimune Group, Inc. | 657.28M |
Market Cap Related Metrics
| Price to Book Value | 2.876 |
| Price | 3.93 |
| Earnings Yield | -11.83% |